HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The use of a sedative neuroleptic agent, sultopride, in posttraumatic Korsakoff syndrome in a young adult].

Abstract
In a young woman with a post-traumatic Korsakoff syndrome exhibiting agitation and anxiety, sedative drugs were difficult to use as they either exacerbated confusion or generated ataxia. Administration of meprobamate with oral sultopride in a high dosage (2 g per day) was promptly followed by an improvement in the patient's condition. Doses were therefore rapidly tapered (over approximately a month and a half). Complete recovery, which is the well-known outcome, thus took place in favorable conditions, as anxiety and agitation no longer hindered the patient's relationships with others.
AuthorsP Cornier
JournalLa semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris (Sem Hop) Vol. 59 Issue 20 Pg. 1556-7 (May 19 1983) France
Vernacular TitleUtilisation d'un neuroleptique sédatif, le sultopride, dans le cadre d'un syndrome de korsakoff post-traumatique chez un adulte jeune.
PMID6308781 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Psychotropic Drugs
  • Sulpiride
  • Amisulpride
  • Meprobamate
Topics
  • Adult
  • Amisulpride
  • Craniocerebral Trauma (complications)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Meprobamate (administration & dosage)
  • Neurocognitive Disorders (drug therapy, etiology)
  • Psychotropic Drugs (administration & dosage)
  • Sulpiride (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: